Hello,
Reading the announcement this is a completely new ovarian test using exosomes similar with Minomic's pancreatic cancer test - both tests are using Exo-Net to isolate the exosomes. The difference is that in UQ test case BARD1 has the exclusive option to licence the technology.
As far as I understand we could have 3 possible ovarian cancers tests
1 - original BARD1 marker -used for screening
2 - SubB2M -used for monitoring
3 - Exosomes - used for screening - if they decide to license the technology- they might park for good BARD1 marker and use this technology
Will see what they will come up with.
DYOR and stay safe
- Forums
- ASX - By Stock
- Ann: BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data
Hello,Reading the announcement this is a completely new ovarian...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
|
|||||
Last
58.5¢ |
Change
0.020(3.54%) |
Mkt cap ! $64.51M |
Open | High | Low | Value | Volume |
57.0¢ | 60.5¢ | 57.0¢ | $30.40K | 51.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 57.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.0¢ | 290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 0.575 |
1 | 14035 | 0.570 |
2 | 12000 | 0.560 |
5 | 18564 | 0.555 |
3 | 53619 | 0.550 |
Price($) | Vol. | No. |
---|---|---|
0.590 | 290 | 1 |
0.600 | 9950 | 5 |
0.610 | 23519 | 4 |
0.620 | 16167 | 2 |
0.625 | 1584 | 1 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online